#48 - Michael Oleksiw, CEO at Pleio
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
#48 - Michael Oleksiw, CEO at Pleio
-
Lu par :
-
De :
À propos de ce contenu audio
Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.
What you'll get out of this episode:
- Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
- Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
- Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
- Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
- Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment
